Dawn Health and Novartis Introduce Cora BC for Breast Cancer Support
In a transformative development aimed at supporting women facing one of life’s most daunting challenges, Dawn Health, in collaboration with pharmaceutical giant Novartis, has launched Cora BC, a comprehensive mobile application tailored for breast cancer patients. The diagnosis of breast cancer often leads to a tumultuous journey filled with numerous challenges, including complex treatment regimens, managing debilitating side effects, and maintaining effective communication with healthcare professionals. It is within this context that Cora BC emerges as a powerful ally, designed to offer practical support and resources at every stage of the treatment process.
Cora BC allows patients to monitor their health effectively, fostering a better understanding of their treatment journey. The app features regular health check-in tools and easy-to-read graphs that visualize progress, empowering users to take charge of their health and treatment plans. Importantly, Cora BC includes customized reminders for medication dosages and appointments, assisting patients in developing and sustaining essential habits that are vital for compliance with long-term treatment requirements.
Recognizing the individual nature of each patient's journey, Cora BC tailors its content to suit the unique circumstances and needs of its users. This includes providing answers to frequently asked questions and offering practical advice that can be accessed precisely when it is most needed. Beyond just educational resources, Cora BC promotes organization through journal entries and preparatory resources for consultations, ultimately leading to more effective discussions with healthcare providers.
Alexander Mandix Hansen, CEO of Dawn Health, emphasized the app's significance, stating, "Cora BC is more than just a tool; it represents a step towards improved patient care. Our partnership with Novartis ensures that breast cancer patients will have the necessary resources and support to feel recognized, understood, and empowered to achieve optimal outcomes. This application underscores our shared commitment to innovation and patient-centered care."
Cora BC is initially launched in Germany, with plans for expansion to the United Kingdom, Canada, Australia, and other markets in the pipeline. While the app does not provide medical advice, diagnoses, or treatment recommendations, it serves as a vital resource for organizing care and enhancing communication between patients and healthcare providers.
This initiative follows a successful collaboration between Dawn Health and Novartis, which previously developed other health applications such as Ekiva MS and Ekiva PNH, illustrating the potential of digital health solutions to revolutionize chronic care management. For more information on Cora BC, interested users are encouraged to visit www.cora-bc.com.
Dawn Health has positioned itself as a leader in digital health, specializing in the development of software as a medical device (SaMD) and digital therapeutics (DTx). By fostering partnerships within the life sciences industry, Dawn Health is dedicated to creating transformative digital health products that significantly improve patient care through an empathetic, human-centered approach.
Cora BC allows patients to monitor their health effectively, fostering a better understanding of their treatment journey. The app features regular health check-in tools and easy-to-read graphs that visualize progress, empowering users to take charge of their health and treatment plans. Importantly, Cora BC includes customized reminders for medication dosages and appointments, assisting patients in developing and sustaining essential habits that are vital for compliance with long-term treatment requirements.
Recognizing the individual nature of each patient's journey, Cora BC tailors its content to suit the unique circumstances and needs of its users. This includes providing answers to frequently asked questions and offering practical advice that can be accessed precisely when it is most needed. Beyond just educational resources, Cora BC promotes organization through journal entries and preparatory resources for consultations, ultimately leading to more effective discussions with healthcare providers.
Alexander Mandix Hansen, CEO of Dawn Health, emphasized the app's significance, stating, "Cora BC is more than just a tool; it represents a step towards improved patient care. Our partnership with Novartis ensures that breast cancer patients will have the necessary resources and support to feel recognized, understood, and empowered to achieve optimal outcomes. This application underscores our shared commitment to innovation and patient-centered care."
Cora BC is initially launched in Germany, with plans for expansion to the United Kingdom, Canada, Australia, and other markets in the pipeline. While the app does not provide medical advice, diagnoses, or treatment recommendations, it serves as a vital resource for organizing care and enhancing communication between patients and healthcare providers.
This initiative follows a successful collaboration between Dawn Health and Novartis, which previously developed other health applications such as Ekiva MS and Ekiva PNH, illustrating the potential of digital health solutions to revolutionize chronic care management. For more information on Cora BC, interested users are encouraged to visit www.cora-bc.com.
Dawn Health has positioned itself as a leader in digital health, specializing in the development of software as a medical device (SaMD) and digital therapeutics (DTx). By fostering partnerships within the life sciences industry, Dawn Health is dedicated to creating transformative digital health products that significantly improve patient care through an empathetic, human-centered approach.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.